BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 25633836)

  • 1. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
    Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
    Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
    Oriowo B; Thirunavukkarasu M; Selvaraju V; Adluri RS; Zhan L; Takeda K; Fong GH; Sanchez JA; Maulik N
    Curr Pharm Des; 2014; 20(9):1305-10. PubMed ID: 23978105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells.
    Liu Y; Huo Z; Yan B; Lin X; Zhou ZN; Liang X; Zhu W; Liang D; Li L; Liu Y; Zhao H; Sun Y; Chen YH
    Biochem Biophys Res Commun; 2010 Oct; 401(2):231-7. PubMed ID: 20849813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
    Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
    Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling.
    Peng K; Chen WR; Xia F; Liu H; Meng XW; Zhang J; Liu HY; Xia ZY; Ji FH
    J Cell Mol Med; 2020 Jan; 24(1):850-861. PubMed ID: 31680420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of HIF-1α/miR-10b-5p/PTEN on Hypoxia-Induced Cardiomyocyte Apoptosis.
    Wu L; Chen Y; Chen Y; Yang W; Han Y; Lu L; Yang K; Cao J
    J Am Heart Assoc; 2019 Sep; 8(18):e011948. PubMed ID: 31480879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
    Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
    Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte-Specific Transgenic Expression of Prolyl-4-Hydroxylase Domain 3 Impairs the Myocardial Response to Ischemia.
    Zieseniss A; Hesse AR; Jatho A; Krull S; Hölscher M; Vogel S; Katschinski DM
    Cell Physiol Biochem; 2015; 36(3):843-51. PubMed ID: 26044310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypoxia-inducible factor 1-alpha on hypoxia/reoxygenation-induced apoptosis in primary neonatal rat cardiomyocytes.
    Wang X; Ma S; Qi G
    Biochem Biophys Res Commun; 2012 Jan; 417(4):1227-34. PubMed ID: 22227185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.
    Schoepflin ZR; Silagi ES; Shapiro IM; Risbud MV
    FASEB J; 2017 Sep; 31(9):3831-3847. PubMed ID: 28495754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury.
    Natarajan R; Salloum FN; Fisher BJ; Kukreja RC; Fowler AA
    Circ Res; 2006 Jan; 98(1):133-40. PubMed ID: 16306444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
    Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
    J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium.
    Natarajan R; Salloum FN; Fisher BJ; Ownby ED; Kukreja RC; Fowler AA
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1571-80. PubMed ID: 17545479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II differentially regulates Morg1 expression in kidney cells.
    Bondeva T; Heinzig J; Franke S; Wolf G
    Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
    Liu S; Ai Q; Feng K; Li Y; Liu X
    Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.